91 related articles for article (PubMed ID: 10565857)
1. Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.
Vanover KE; Edgar DM; Seidel WF; Hogenkamp DJ; Fick DB; Lan NC; Gee KW; Carter RB
J Pharmacol Exp Ther; 1999 Dec; 291(3):1317-23. PubMed ID: 10565857
[TBL] [Abstract][Full Text] [Related]
2. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.
Edgar DM; Seidel WF; Gee KW; Lan NC; Field G; Xia H; Hawkinson JE; Wieland S; Carter RB; Wood PL
J Pharmacol Exp Ther; 1997 Jul; 282(1):420-9. PubMed ID: 9223583
[TBL] [Abstract][Full Text] [Related]
3. Behavioral characterization of Co 134444 (3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha- pregnan-20-one), a novel sedative-hypnotic neuroactive steroid.
Vanover KE; Hogenkamp DJ; Lan NC; Gee KW; Carter RB
Psychopharmacology (Berl); 2001 May; 155(3):285-91. PubMed ID: 11432691
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic treatment with triazolam on operant responding in rats.
Cohen C; Sanger DJ
Pharmacol Biochem Behav; 1994 Nov; 49(3):455-61. PubMed ID: 7862694
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats.
Gunter BW; Platt DM; Rowlett JK
Pharmacol Biochem Behav; 2015 Oct; 137():53-9. PubMed ID: 26255153
[TBL] [Abstract][Full Text] [Related]
8. Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872.
Sanger DJ; Joly D; Zivkovic B
Psychopharmacology (Berl); 1986; 90(2):207-10. PubMed ID: 2878460
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects.
Gunter BW; Jones SA; Paul IA; Platt DM; Rowlett JK
Psychopharmacology (Berl); 2016 Sep; 233(17):3237-47. PubMed ID: 27356519
[TBL] [Abstract][Full Text] [Related]
10. Pregnenolone and ganaxolone reduce operant ethanol self-administration in alcohol-preferring p rats.
Besheer J; Lindsay TG; O'Buckley TK; Hodge CW; Morrow AL
Alcohol Clin Exp Res; 2010 Dec; 34(12):2044-52. PubMed ID: 20946297
[TBL] [Abstract][Full Text] [Related]
11. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
[TBL] [Abstract][Full Text] [Related]
12. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.
Sanger DJ; Zivkovic B
Psychopharmacology (Berl); 1986; 89(3):317-22. PubMed ID: 2873608
[TBL] [Abstract][Full Text] [Related]
13. Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats.
Takahashi H; Yoshimoto M; Higuchi H; Shimizu T; Hishikawa Y
Eur Neuropsychopharmacol; 1999 Jun; 9(4):317-21. PubMed ID: 10422892
[TBL] [Abstract][Full Text] [Related]
14. The negative GABA(A) modulator methyl beta-carboline-3-carboxylate attenuates the behavioral effects of the positive GABA(A) modulators triazolam and pregnanolone in rhesus monkeys.
McMahon LR; France CP
Psychopharmacology (Berl); 2001 Nov; 158(3):289-96. PubMed ID: 11713619
[TBL] [Abstract][Full Text] [Related]
15. The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations.
Lau CE; Sun L; Wang Q; Falk JL
Behav Pharmacol; 2002 Mar; 13(2):93-103. PubMed ID: 11981222
[TBL] [Abstract][Full Text] [Related]
16. Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys.
McMahon LR; France CP
Psychopharmacology (Berl); 2005 Apr; 178(4):400-9. PubMed ID: 15765255
[TBL] [Abstract][Full Text] [Related]
17. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to the rate-increasing and not rate-decreasing effects of pregnanolone in rats.
Eppolito AK; Gerak LR
Behav Pharmacol; 2010 Dec; 21(8):736-44. PubMed ID: 20859199
[TBL] [Abstract][Full Text] [Related]
19. Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia.
Chuck TL; McLaughlin PJ; Arizzi-LaFrance MN; Salamone JD; Correa M
Life Sci; 2006 Jun; 79(2):154-61. PubMed ID: 16487981
[TBL] [Abstract][Full Text] [Related]
20. Modification of behavioral effects of drugs in mice by neuroactive steroids.
Ungard JT; Beekman M; Gasior M; Carter RB; Dijkstra D; Witkin JM
Psychopharmacology (Berl); 2000 Mar; 148(4):336-43. PubMed ID: 10928304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
